You are here: Home » Markets » News
Business Standard

Market Wrap, Feb 26: Sensex ends 392 pts lower, Nifty at 11,678

Among sectoral indices, Nifty Auto index slipped the most - over 2 per cent to 7,208 levels. Nifty Metal index dropped 1.63 per cent to 2,430

Topics
MARKET WRAP | Markets | India Cements

BS Web Team  |  New Delhi 

Extending their losses for the fourth day in a row, benchmark indices ended Wednesday's highly volatile session in the negative territory as the rapid spread of from its epicentre in China to other countries dented investors' risk appetite. So far, the total number of coronavirus-related deaths in China has crossed over 2,700, while the number of confirmed cases in mainland China hit 78,064, including 406 new cases. CLICK TO READ MORE

The S&P BSE Sensex ended below the crucial psychological level of 40,000 at 39,889, down 392 points or around a per cent. Reliance Industries (RIL), Infosys, ICICI Bank, and HDFC contributed the most to the index's decline. Drug major Sun Pharma ended as the biggest loser on the index - down over 3.5 per cent while SBI ended as the biggest gainer on the index with half a per cent gain.

On the NSE, the Nifty50 index closed the session at 11,678.5, down 119 points or 1 per cent with 44 out of 50 stocks ending in the red and just 6 in the green.

In the broader market, the Nifty Midcap 100 index skid over a per cent to settle at 17,512 while the Nifty SmallCap 100 index ended at 5,992, down 34 points or 0.57 per cent.

India VIX, the "fear guage", climbed over 8 per cent to 18.29 levels.

Among sectoral indices, Nifty Auto index slipped the most - over 2 per cent to 7,208 levels. Nifty Metal index dropped 1.63 per cent to 2,430 while the Nifty Realty index ended at 297.50, down around 1.7 per cent.

Individual Stocks


Shares of commodities and specialty chemicals companies were on a roll on Wednesday with Navin Fluorine International (NFIL), Fairchem Speciality and Neogen Chemicals rallying more than 10 per cent on the BSE in an otherwise weak market on expectation of strong earnings growth going forward.

Shares of surged 18.5 per cent to Rs 103.35 on Wednesday, thus rallying over 37 per cent in the past two trading days after Gopikishan Damani bought 2.75 per cent stake in the company for a total amount of Rs 70.5 crore via open market.

On Tuesday, Gopikishan S Damani had purchased 8.52 million shares in at an average price of Rs 82.70 apiece, NSE bulk deal data showed.

Shares of hit a record high of Rs 7,638, surging 9 per cent, on the BSE on Wednesday after the pharmaceutical company announced a total dividend of Rs 349 per share.

GLOBAL MARKETS

Asian shares fell on Wednesday as a US warning to Americans to prepare for the possibility of a pandemic jolted Wall Street yet again and pushed yields on safe-haven Treasuries to record lows. MSCI’s broadest index of Asia-Pacific shares outside Japan was down 1.1 per cent. Japan was among the worst-performing market in the region, weighed by growing concerns the virus could force the cancellation of the Tokyo Olympics.

Euro Stoxx 50 futures were down 0.36 per cent, German DAX futures fell 0.53 per cent, while FTSE futures were off 0.4 per cent.

Crude prices edged up on Wednesday as investors covered short positions after three sessions of losses, even as fears deepened that the rapid spread of the will lead to a global pandemic.

Read by: Sukanya Roy

MONTHLY STAR

Business Standard Digital

Business Standard Digital Monthly Subscription
149.00  
subscribe
Complete access to the premium product
Convenient - Pay as you go
Pay using Master/Visa Credit Card & ICICI VISA Debit Card
Auto renewed (subject to your card issuer's permission)
Cancel any time in the future
Requires personal information

What you get?

ON BUSINESS STANDARD DIGITAL

  • Unlimited access to all the content on any device through browser or app.
  • Exclusive content, features, opinions and comment – hand-picked by our editors, just for you.
  • Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
  • Track the industry of your choice with a daily newsletter specific to that industry.
  • Stay on top of your investments. Track stock prices in your portfolio.
  • 18 years of archival data.

NOTE :

  • The product is a monthly auto renewal product.
  • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
  • To cancel, communicate from your registered email id and send the email with the cancellation request to assist@bsmail.in. Include your contact number for speedy action. Requests mailed to any other ID will not be acknowledged or actioned upon.

SMART MONTHLY

Business Standard Digital

Business Standard Digital - 12 Months
1499.00
subscribe
Get 12 months of Business Standard digital access
Single Seamless Sign-up to Business Standard Digital
Convenient - Once a year payment
Pay using an instrument of your choice - Credit/Debit Cards, Net Banking, Payment Wallets accepted
Exclusive Invite to select Business Standard events

What you get

ON BUSINESS STANDARD DIGITAL

  • Unlimited access to all content on any device through browser or app.
  • Exclusive content, features, opinions and comment - hand-picked by our editors, just for you.
  • Pick 5 of your favourite companies. Get a daily email with all the news updates on them.
  • Track the industry of your choice with a daily newsletter specific to that industry.
  • Stay on top of your investments. Track stock prices in your portfolio.

NOTE :

  • This product is a monthly auto renewal product.
  • Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal. We do not offer any refunds.
  • To cancel, communicate from your registered email id and send the mail with the request to assist@bsmail.in. Include your contact number for easy reference. Requests mailed to any other ID will not be acknowledged or actioned upon.

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Wed, February 26 2020. 16:54 IST
RECOMMENDED FOR YOU
.